Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Intrexon Reports In-Line Loss In Q3, Revenues Miss
Article By:
Zacks Investment Research
Wednesday, November 9, 2016 4:05 PM EDT
Shares of Intrexon Corporation have risen more than 4% since it announced its third quarter results.
Kite Pharma (KITE) Q2 Loss Wider But Focus Is On KTE-C19
Article By:
Arpita Dutt
Tuesday, August 9, 2016 10:35 AM EDT
Kite’s research and development expenses shot up 185.5% from the year-ago period to $47.4 million in the reported quarter, general and administrative expenses were $23.5 million, up 140.6% from the year-ago period.
Heska - Chart Of The Day
Article By:
Jim Van Meerten
Wednesday, December 30, 2015 12:35 PM EDT
Earnings estimated to increase by 51.20% this year, an additional 30.60% next year and continue to compound at an annual rate of 27.15% for the next 5 years.
In this article: HSKA